The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Cerebrovascular and Brain Morphologic Correlates of Mild Cognitive Impairment in the National Heart, Lung, and Blood Institute Twin Study
Abstract
OBJECTIVE: To evaluate the relative risk (RR) of mild cognitive impairment (MCI) associated with cerebrovascular risk factors and cerebrovascular-related brain changes. DESIGN: Mild cognitive impairment was determined for the subjects of the prospective National Heart, Lung, and Blood Institute Twin Study. Quantitative measures of brain, white matter hyperintensity, cerebral infarction, apolipoprotein E genotype, and psychometric testing were obtained. RESULTS: Subjects with MCI were older (73.5 +/- 3.0 vs 72.1 +/- 2.8 years), consumed less alcohol (3.7 +/- 5.8 vs 7.0 +/- 10.7 drinks per week), had greater white matter hyperintensity volumes (0.56% +/- 0.82% vs 0.25% +/- 0.34% of cranial volume), and had an increased prevalence of apolipoprotein E4 genotype (31.4% vs 19.2%) than normal subjects. White matter hyperintensity and the presence of the apolipoprotein E4 genotype were associated with a significantly increased risk for MCI. When all subjects were included in the analysis, alcohol consumption was associated with a reduced risk for MCI (RR = 0.93, P<.05). When subjects with a history of symptomatic cerebrovascular disease were excluded from the analysis, elevated midlife diastolic blood pressure was associated with an increased risk for MCI (RR = 1.70, P<.05). CONCLUSIONS: Elevated midlife blood pressures, and the resulting increased white matter hyperintensities, increase the risk for MCI in a group of community-dwelling older men to at least the same degree as apolipoprotein E4 genotype. Given the common occurrence of elevations in midlife blood pressure, early and effective treatment may be warranted to prevent late-life brain abnormalities and MCI. Moreover, since many individuals with MCI progress to clinical dementia, longitudinal evaluations of this cohort will be important.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
EDF Statistics for Goodness of Fit and Some Comparisons
Stephens, M. A. (1974) · Journal of the American Statistical Association · doi:10.1080/01621459.1974.10480196 · Cited by 3,166
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590 · cited 1×
“Alternatively, recent evidence suggests that cerebrovascular disease may interact significantly with pathologic changes of AD to enhance the expression of clinical dementia.(50) It is possible that a similar phenomenon could occur with WMHI.”
BackgroundLongstreth, W. T., Manolio, T. A., Arnold, A., Burke, G. L., Bryan, N., Jungreis, C. A., Enright, P. L., O'Leary, D., & Fried, L. (1996) · Stroke · doi:10.1161/01.str.27.8.1274 · Cited by 1,464
California Verbal Learning Test
Delis, D. C., Freeland, J., Kramer, J. H., & Kaplan, E. (2016) · PsycTESTS Dataset · doi:10.1037/t48844-000 · Cited by 1,319
Genetic associations with human longevity at the APOE and ACE loci
Schächter, F., Faure-Delanef, L., Guénot, F., Rouger, H., Froguel, P., Lesueur-Ginot, L., & Cohen, D. (1994) · Nature Genetics · doi:10.1038/ng0194-29 · Cited by 1,095
Launer, L. J. (1995) · JAMA · doi:10.1001/jama.1995.03530230032026 · Cited by 908
Stampfer, M. J., Colditz, G. A., Willett, W. C., Speizer, F. E., & Hennekens, C. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808043190503 · Cited by 903
Cabeza, R., Grady, C. L., Nyberg, L., McIntosh, A. R., Tulving, E., Kapur, S., Jennings, J. M., Houle, S., & Craik, F. I. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00391.1997 · Cited by 826
Cited by
The clinical use of structural MRI in Alzheimer disease
Frisoni, G. B., Fox, N. C., Jack, C. R., Scheltens, P., & Thompson, P. M. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.215 · Cited by 2,113
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Arnold, S. E., Arvanitakis, Z., Macauley-Rambach, S. L., Koenig, A. M., Wang, H.-Y., Ahima, R. S., Craft, S., Gandy, S., Buettner, C., Stoeckel, L. E., et al. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.185 · Cited by 1,597
(2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,166
Alzheimer Disease as a Vascular Disorder: Nosological Evidence
de la Torre, J. C. (2002) · Stroke · doi:10.1161/01.str.0000014421.15948.67 · Cited by 853
Mediterranean Diet and Mild Cognitive Impairment
Scarmeas, N., Stern, Y., Mayeux, R., Manly, J. J., Schupf, N., & Luchsinger, J. A. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.536 · Cited by 757
DeCarli, C., Massaro, J., Harvey, D., Hald, J., Tullberg, M., Au, R., Beiser, A., D’Agostino, R., & Wolf, P. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.05.004 · Cited by 680
Self-citationPortet, F. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.085332 · Cited by 652
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
DeCarli, C. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00262-x · Cited by 573
Self-citationVascular risk factors, incidence of MCI, and rates of progression to dementia
Solfrizzi, V., Panza, F., Colacicco, A. M., D’Introno, A., Capurso, C., Torres, F., Grigoletto, F., Maggi, S., Del Parigi, A., Reiman, E. M., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144281.38555.e3 · Cited by 530
Impact of diabetes on cognitive function and brain structure
Moheet, A., Mangia, S., & Seaquist, E. R. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12807 · Cited by 510
DeCarli, C., Fletcher, E., Ramey, V., Harvey, D., & Jagust, W. J. (2005) · Stroke · doi:10.1161/01.str.0000150668.58689.f2 · Cited by 496
Self-citationWhite matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study
Medina, D., deToledo-Morrell, L., Urresta, F., Gabrieli, J. D. E., Moseley, M., Fleischman, D., Bennett, D. A., Leurgans, S., Turner, D. A., & Stebbins, G. T. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.026 · Cited by 492
Smoking and increased Alzheimer's disease risk: A review of potential mechanisms
Durazzo, T. C., Mattsson, N., Weiner, M. W., & Initiative, A. D. N. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.04.009 · Cited by 451
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD
Yoshita, M., Fletcher, E., Harvey, D., Ortega, M., Martinez, O., Mungas, D. M., Reed, B. R., & DeCarli, C. S. (2006) · Neurology · doi:10.1212/01.wnl.0000249119.95747.1f · Cited by 434
“Similar to others, we also found that the overall burden of WMH was increased with both vascular risk and the degree of cognitive impairment.(5,6,8) We believe, however, that this is the first study show a change in rostral-caudal distribution in periventricular area associated with increasing vascular risk and cognit…”
ResultSelf-citationStructural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion
Scheltens, P., Fox, N., Barkhof, F., & De Carli, C. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00002-9 · Cited by 410
Self-citationAu, R., Massaro, J. M., Wolf, P. A., Young, M. E., Beiser, A., Seshadri, S., D’Agostino, R. B., & DeCarli, C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.2.246 · Cited by 381
Self-citationVascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
Li, J., Wang, Y. J., Zhang, M., Xu, Z. Q., Gao, C. Y., Fang, C. Q., Yan, J. C., & Zhou, H. D. (2011) · Neurology · doi:10.1212/wnl.0b013e318217e7a4 · Cited by 367
Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease
Frisardi, V., Solfrizzi, V., Seripa, D., Capurso, C., Santamato, A., Sancarlo, D., Vendemiale, G., Pilotto, A., & Panza, F. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.04.007 · Cited by 357
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment
Korf, E. S. C., Wahlund, L.-O., Visser, P. J., & Scheltens, P. (2004) · Neurology · doi:10.1212/01.wnl.0000133114.92694.93 · Cited by 343
MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET
Mosconi, L., Perani, D., Sorbi, S., Herholz, K., Nacmias, B., Holthoff, V., Salmon, E., Baron, J.-C., De Cristofaro, M. T. R., Padovani, A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000147469.18313.3b · Cited by 343
Neuropathological basis of magnetic resonance images in aging and dementia
Jagust, W. J., Zheng, L., Harvey, D. J., Mack, W. J., Vinters, H. V., Weiner, M. W., Ellis, W. G., Zarow, C., Mungas, D., Reed, B. R., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21296 · Cited by 302
“Research studies have linked brain atrophy, especially in the hippocampus and medial temporal lobe structures, to clinically diagnosed Alzheimer’s disease (AD), and prediction of AD in patients with mild cognitive impairment,(5,6) whereas epidemiological studies show convincing associations between white matter hyperi…”
BackgroundSelf-citationTervo, S., Kivipelto, M., Hänninen, T., Vanhanen, M., Hallikainen, M., Mannermaa, A., & Soininen, H. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000076356 · Cited by 298
Cigarette Smoking and Alcohol Consumption in Relation to Cognitive Performance in Middle Age
Kalmijn, S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf135 · Cited by 281
Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia
DeCarli, C., Mungas, D., Harvey, D., Reed, B., Weiner, M., Chui, H., & Jagust, W. (2004) · Neurology · doi:10.1212/01.wnl.0000130531.90205.ef · Cited by 271
Self-citationIncreased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment
Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260
Carmichael, O. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.284 · Cited by 248
Wen, W., Sachdev, P. S., Li, J. J., Chen, X., & Anstey, K. J. (2009) · Human Brain Mapping · doi:10.1002/hbm.20586 · Cited by 210
Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease
Bondi, M. W., Jak, A. J., Delano-Wood, L., Jacobson, M. W., Delis, D. C., & Salmon, D. P. (2008) · Neuropsychology Review · doi:10.1007/s11065-008-9054-1 · Cited by 216
Moderate alcohol consumption and cognitive risk
Neafsey, E., & Collins, M. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s23159 · Cited by 205
Coevolution of white matter hyperintensities and cognition in the elderly
Maillard, P., Carmichael, O., Fletcher, E., Reed, B., Mungas, D., & DeCarli, C. (2012) · Neurology · doi:10.1212/wnl.0b013e3182617136 · Cited by 172
Self-citationThe enigma of vascular cognitive disorder and vascular dementia
Jellinger, K. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0185-2 · Cited by 166
Scuteri, A., Brancati, A. M., Gianni, W., Assisi, A., & Volpe, M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000170384.38708.b7 · Cited by 162
The epidemiologic study of dementia: a life-long quest?
Launer, L. J. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.016 · Cited by 142
Regional pattern of white matter microstructural changes in normal aging, MCI, and AD
Lee, D. Y., Fletcher, E., Martinez, O., Ortega, M., Zozulya, N., Kim, J., Tran, J., Buonocore, M., Carmichael, O., & DeCarli, C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c33afb · Cited by 122
Self-citationCirculating Biomarkers of Cognitive Decline and Dementia
Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120
Decline in intelligence is associated with progression in white matter hyperintensity volume
Garde, E. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.055905 · Cited by 118
Vascular and cognitive functions associated with cardiovascular disease in the elderly
Cohen, R. A., Poppas, A., Forman, D. E., Hoth, K. F., Haley, A. P., Gunstad, J., Jefferson, A. L., Tate, D. F., Paul, R. H., Sweet, L. H., et al. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390802014594 · Cited by 112
Dadar, M., Manera, A. L., Ducharme, S., & Collins, D. L. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.11.007 · Cited by 78
Forti, P., Maioli, F., Pisacane, N., Rietti, E., Montesi, F., & Ravaglia, G. (2007) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2007.01.023 · Cited by 60
Kumar, R., Parslow, R. A., Jorm, A. F., Rosenman, S. J., Maller, J., Meslin, C., Anstey, K. J., Christensen, H., & Sachdev, P. S. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089251 · Cited by 31
Tarawneh, R. (2023) · Biomolecules · doi:10.3390/biom13050830 · Cited by 29
Wang, Z., Dai, Z., Shu, H., Liu, D., Guo, Q., He, Y., & Zhang, Z. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160724 · Cited by 26
Vascular cognitive impairment: prodrome to VaD?
Mayda, A., & DeCarli, C. (2009) · Vascular Cognitive Impairment in Clinical Practice · doi:10.1017/cbo9780511575976.003 · Cited by 7
Self-citation
Metadata
- Authors
- DeCarli, C., Miller, B. L., Swan, G. E., Reed, T., Wolf, P. A., & Carmelli, D.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2001-04-01
- Volume
- 58
- Issue
- 4
- Pages
- 643-7
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2035813868
- Cited by
- 267
- References
- 53
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.